What question did this study set out to answer?

To explore a biology-driven approach to antiplatelet therapy in relation to thrombotic risk following CABG surgery.

April 24, 2026

Antiplatelet Therapy After CABG—Toward a Mechanistic Approach

Resultado clave

A biology-driven approach to antiplatelet therapy after coronary artery bypass graft surgery is proposed to align treatment with patients' evolving thrombotic risk.

Puntos clave

To explore a biology-driven approach to antiplatelet therapy in relation to thrombotic risk following CABG surgery.
Discussion of biological mechanisms related to thrombotic risk.
Analysis of current antiplatelet therapy strategies post-CABG.
Proposes an innovative, mechanistic framework for antiplatelet therapy.
Highlights the need for personalized treatment based on evolving thrombotic risks.

PICO estructurado

Población

Patients after coronary artery bypass graft (CABG) surgery

Intervención

Antiplatelet therapy aligned with evolving thrombotic risk (biology-driven concept)

Proposes a novel, biology-driven approach to align antiplatelet therapy with evolving thrombotic risk following CABG surgery.

Resumen

This Viewpoint discusses a novel, biology-driven concept aligning antiplatelet therapy with evolving thrombotic risk after coronary artery bypass graft (CABG) surgery.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Sigrid Sandner

Raffaele De Caterina

Mario Gaudino

Journals

JAMA Cardiology

Actions

Institutions

Cornell University

Medical University of Vienna

University of Pisa

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Antiplatelet Therapy After CABG—Toward a Mechanistic Approach

Resultado clave

Puntos clave

PICO estructurado

Resumen

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study